Centerpoint Advisors’s Amgen AMGN Stock Holding History

Centerpoint Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Hold	28	–	–	﹤0.01%	315
2025 Q4	$9K	Sell	28 -8	-22%	-$2.54K	﹤0.01%	323
2025 Q3	$10K	Sell	36 -77	-68%	-$22.3K	﹤0.01%	329
2025 Q2	$32K	Sell	113 -71	-39%	-$20.1K	0.01%	184
2025 Q1	$57K	Hold	184	–	–	0.02%	152
2024 Q4	$48K	Hold	184	–	–	0.02%	181
2024 Q3	$59K	Hold	184	–	–	0.02%	160
2024 Q2	$57K	Buy	+184	New	+$54.1K	0.02%	156
2021 Q3	–	Sell	-34	Closed	-$8K	–	292
2021 Q2	$8K	Buy	+34	New	+$8.36K	﹤0.01%	211
2021 Q1	–	Sell	-33	Closed	-$8K	–	267
2020 Q4	$8K	Hold	33	–	–	0.01%	176
2020 Q3	$8K	Hold	33	–	–	0.01%	152
2020 Q2	$8K	Hold	33	–	–	0.01%	165
2020 Q1	$7K	Hold	33	–	–	0.01%	158
2019 Q4	$8K	Hold	33	–	–	0.01%	175
2019 Q3	$6K	Hold	33	–	–	﹤0.01%	184
2019 Q2	$6K	Buy	+33	New	+$5.91K	﹤0.01%	178
2018 Q2	–	Sell	-41	Closed	-$7K	–	366
2018 Q1	$7K	Buy	+41	New	+$7.53K	0.01%	170

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Centerpoint Advisors's AMGN Position: Q1 2026 in Review

Centerpoint Advisors held its Amgen (AMGN) position steady in Q1 2026 at 28 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Centerpoint Advisors first reported a position in AMGN in Q1 2018 and has held it in 17 quarters since. The position peaked at $59K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Centerpoint Advisors held 28 shares of Amgen worth $10K as of Q1 2026.
Centerpoint Advisors left its Amgen share count unchanged in Q1 2026.
Amgen made up ﹤0.01% of Centerpoint Advisors's portfolio in Q1 2026, its #315 holding.
Centerpoint Advisors first reported a position in Amgen in Q1 2018 and has held it in 17 quarters since.
Centerpoint Advisors's Amgen position peaked at $59K in Q3 2024.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Centerpoint Advisors's 13F filing for Q1 2026, filed 7 May 2026.